# Novartis d.o.o. – FDA Inspection, Jul 21, 2023

Source: https://www.keypedia.com/records/fda_inspections/novartis-doo/be1f8dbf-ec85-4afd-ab0b-b5d25b8b0ca7
Source feed: FDA_Inspections

> FDA inspection 1215215 of Novartis d.o.o., July 21, 2023. Form 483 issued. 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1215215
- Company Name: Novartis d.o.o.
- Inspection Date: 2023-07-21
- Center: Human Drugs
- Office Name: Office of Inspections and Investigations
- Citation Count: 0

## Related Documents

- FDA Inspection 1228827 - 2022-09-21
- [FDA Inspection 1155320 - 2020-09-11](https://www.keypedia.com/records/fda_inspections/novartis-doo/4bf055c1-d709-40df-8e9a-cbe4a310aab7)
- FDA Inspection 1004338 - 2017-02-13
- FDA Inspection 945699 - 2015-09-18
- FDA Inspection 807398 - 2012-10-19

## Related Officers

- [Liqun Zhao](https://www.keypedia.com/people/liqun-zhao/6fdfb753-7788-4351-9b0b-65e06c201bc5)

Company: https://www.keypedia.com/companies/novartis-doo/55471e35-a203-4edf-a4b9-fe1ad0bb16fd

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8